This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Baker, D

Giovannoni, G

Jackson, SJ

Journal of Neuroinflammation

English

PubMed

Queen Mary Research Online

A: Cytotoxic actions of FTY720, a novel immunosuppressant, on thymocytes and brain neurons dissociated from the rat.

al: Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

al: Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.

al: The immune modulator FTY720 targets sphingosine 1-phosphate receptors.

Antel JP: Cyclical and dosedependent responses of adult human mature oligodendrocytes to fingolimod.

Antel JP: Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Antel JP: FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol

Asou H: Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP.

Baumruker T: FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol

Billich A: Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther

Blakemore WF: Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin.

Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience

Cannabinoids and neuroprotection in CNS inflammatory disease.

Chiba K: FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol

Coles A: Multiple sclerosis. Lancet

Cuzner ML: Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment. JNeurosciRes

Cuzner ML: Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. JNeurosciRes

Cuzner ML: Remyelination of cytokineor antibody-demyelinated CNS aggregate cultures is inhibited by macrophage supplementation. GLIA

Developmental changes in the basic proteins of normal and jimpy mouse brain. Biochemical and biophysical research communications

Diemel LT: Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a threedimensional mouse brain aggregate cell culture.

et al: A monoselective sphingosine1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol

et al: Fingolimod provides long-term protection in rodent models of cerebral ischemia.

et al: Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.

et al: Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol

Hartung HP: Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci

HD: Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures. Brain Res

Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis. Mult Scler

Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology

Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development

KK: Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology

Li XK: Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther

Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia

Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia

Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism.

Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis.

McAlpine’s Multiple Sclerosis. Churchill Livingstone;

MD: Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes.

Microglial activation state and lysophospholipid acid receptor expression.

Monnet-Tschudi F: Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions.

Myelinated, synapsing cultures of murine spinal cord– validation as an in vitro model of the central nervous system.

Myelination of aggregating foetal rat brain cell cultures grown in a chemically defined medium. Neurological mutations affecting myelination

R: FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.

Radue EW: Oral fingolimod (FTY720) for relapsing multiple sclerosis.

Relvas JB: Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination.

RJ: Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol

S: Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem

Sato-Bigbee C: The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther

SatoBigbee C: Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors.

Schluesener HJ: Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. Neuropathol Appl Neurobiol

Schluesener HJ: FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.

SM: Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline.

Soliven B: Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia

Soliven B: Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.

Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther

T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia

Teunissen CE: An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. GLIA

The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.

TS: Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

Tse FL: Quantitative determination of BAF312, a S1P-R modulator, in human urine by LC-MS/MS: prevention and recovery of lost analyte due to container surface adsorption.

VE: Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies. Clin Neurol Neurosurg

What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS One

Fingolimod modulates microglial activation to augment markers of remyelination

Samuel J Jackson

Gavin Giovannoni

David Baker

Springer - Publisher Connector

Abstract Introduction Microglial activation in multiple sclerosis has been postulated to contribute to long-term neurodegeneration during disease. Fingolimod has been shown to impact on the relapsing remitting phase of disease by modulating autoreactive T-cell egress from lymph organs. In addition, it is brain penetrant and has been shown to exert multiple effects on nervous system cells. Methods In this study, the impact of fingolimod and other sphingosine-1-phosphate receptor active molecules following lysophosphotidyl choline-induced demyelination was examined in the rat telencephalon reaggregate, spheroid cell culture system. The lack of immune system components allowed elucidation of the direct effects of fingolimod on CNS cell types in an organotypic situation. Results Following demyelination, fingolimod significantly augmented expression of myelin basic protein in the remyelination phase. This increase was not associated with changes in neurofilament levels, indicating de novo myelin protein expression not associated with axonal branching. Myelin wrapping was confirmed morphologically using confocal and electron microscopy. Increased remyelination was associated with down-regulation of microglial ferritin, tumor necrosis factor alpha and interleukin 1 during demyelination when fingolimod was present. In addition, nitric oxide metabolites and apoptotic effectors caspase 3 and caspase 7 were reduced during demyelination in the presence of fingolimod. The sphingosine-1-phosphate receptor 1 and 5 agonist BAF312 also increased myelin basic protein levels, whereas the sphingosine-1-phosphate receptor 1 agonist AUY954 failed to replicate this effect on remyelination. Conclusions The results presented indicate that modulation of S1P receptors can ameliorate pathological effectors associated with microglial activation leading to a subsequent increase in protein and morphological markers of remyelination. In addition, sphingosine-1-phosphate receptor 5 is implicated in promoting remyelination in vitro. This knowledge may be of benefit for treatment of chronic microglial inflammation in multiple sclerosis.</p

Baker David

Giovannoni Gavin

Jackson Samuel J

Directory of Open Access Journals

Crossref

file:///data/remote/core/dit/data/Springer-OA/pdf/f4b/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvMTc0Mi0yMDk0LTgtNzYucGRm.pdf

Fingolimod modulates microglial activation to augment markers of remyelination

Abstract

Similar works

Full text

Available Versions

Queen Mary Research Online

Springer - Publisher Connector

Directory of Open Access Journals

Queen Mary Research Online

Springer - Publisher Connector

Crossref